Background: The prevalence of hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) is high and its in vitro diagnostic is a challenge. The basophil activation test with determination by flow cytometry (FC), of the expression rate of CD63 molecules has been much studied today. NSAIDs several have been evaluated by this technique, which still didn't happen with indomethacin; however, that we may study it is necessary to assess their effects, concentration dependants, on cell viability. We studied the viability of indomethacin dissolved in propylene glycol, analyzing the nonspecific stimulation and cytotoxicity, using in this case the basophil activation test with the use of FC. Methods: First it was studied the safe concentration of propylene glycol for dilution of indomethacin, incubating basophils from atopic donor with this diluent. In the second phase, the indomethacin was diluted in the following concentrations: 10 mcg/mL, 1 mcg/mL, 0.1 mcg/mL and the CD63 intensity molecules expression was analysed by FC. Results: Regarding the toxicity of propylene glycol, concentrations less than or equal to 0.5% are safe. For indomethacin, the used concentrations (10 mcg/ mL, 1 mcg/mL e 0.1 mcg/mL) were viable showing absence of cytotoxicity or nonspecific stimulation. Conclusions: Propylene glycol as a diluent of indomethacin is necessary to make at concentrations less than or equal to 0.5%. The indomethacin at concentrations of 10 mcg/mL, 1 mcg/mL and 0.1 mcg/mL proved to be not cytotoxic and without nonspecific stimulant action to basophils. Calixto García University Hospital, Havana City, Cuba. Background: Aspirin (ASA) is one of the best known and most widely used drugs in the world. Patients with coronary artery disease require prolonged treatments with this drug, which is denied to those patients with histories of adverse reactions to it. Methods: In a rapid desensitization protocol a patient with a history of ASAinduced urticaria-angioedema was treated with escalating doses of aspirin administered orally every 25 minutes. Results: The patient completed the desensitization protocol in few hours without complications, and currently is able to take 125 mg of ASA per day without adverse reactions. Conclusions: This report describes the first desensitization treatment with aspirin carried out in our hospital. No other case was found in the national bibliography. Department of Pharmacy, Inha Regional Pharmacovigilance Center, Inha University Hospital, Incheon, South Korea. Background: The number of self-reported adverse drug reactions (ADRs) has been rapidly increased with the active pharmacovigilance activities in Korea. However, there has been few data on ADRs to anti-asthmatics in Korea. This study was conducted to investigate the clinical characteristics of ADRs to anti-asthmatics in adult patients with bronchial asthma. Methods: ADRs to anti-asthmatics reported to Regional Pharmacovigilance Center of Inha University Hospital by 2 physicians were collected from January 2011 to April 2011. Causality assessment of adverse events was performed by using WHO-UMC criteria and Naranjo's probability scale. Clinical information was additionally collected from electronic medical records. Results: Twenty five ADRs to anti-asthmatics were reported in 19 (male 5, female 14) out of 228 patients with asthma. The most common offending anti-asthmatics were inhaled glucocorticoids combined with inhaled longacting beta agonist (LABA) (12 of 19 subjects, 63.2%), theobromine (10.5%), oral LABA (10.5%), doxofylline (5.3%), acetylcysteine (5.3%), and montelukast (5.3%). Severity of ADRs was mild in most patients (13 of 19, 68.5%), and no severe ADR was detected. By frequency, oral LABA was the commonest drug associated with ADRs (2 in 17 prescription, 11.8%). ADR frequency was not different according to asthma control status. But ADRs to simultaneously prescribed drugs were more frequently detected in patients with combined upper airway diseases (ADRs to antihistamines) or patients with combined infection (ADRs to antiinfective drugs, mucolytics, oral LABA, or to SABA), or older patients with asthma. Conclusions: Although the severity is usually mild, ADRs are relatively common in patients with bronchial asthma. Physician should monitor ADRs to anti-asthmatics or related drugs in patients with asthma, especially in older patients or in patients with multiple drug treatment for combined conditions. Background: Triptorelin is a drug that is frequently used in pediatrics to treat precocious puberty -an often condition in childhood endocrinology services. Despite its widespread use, there is not much research on hypersensitivity reactions to this drug. We found 3 patients that have suffered allergic reaction during the treatment with Triptorelin. Methods: We treated three 8 year old girls diagnosed with precocious puberty that have suffered allergic reaction during the treatment with Triptorelin.Patient 1: An hour after the first dose the patient broke out in a rash over her face, trunk and upper limbs. She also showed general paleness, conjunctival erythema, arthralgia and joint swelling in both knees with functional impotence of the lower limbs.Patient 2: Five minutes after the second dose the patient showed anaphylactic reaction.Patient 3: Two hours after the second dose the patient showed generalized urticaria and tachycardia. Results: Once overcome those events. We started to provoke the reaction by doing the progressive-controlled triptorelin test. Finally we could confirm the hypersensitivity reaction to this drug Conclusions: The triptorelin is a drug that may cause hypersensitivity reaction. So, after the first application, we recommend to monitor the patient and also plan some actions to avoid a possible anaphylactic shock event.
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